Bryaconeel

Medicinal product

(Invented) name

Bryaconeel

Active substance (s)

Bryonia cretica D4/Aconitum napellus D4/Phosphorus D5

Strength

120 mg/150 mg/30 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

Marketing authorisation holder

Biologische Heilmittel Heel GmbH, Vokietija

Date of authorisation

2000-11-09

Date of renewal

2012-02-28

Documents

2814_1 Bryaconeel_tab RPP 160830.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

16.2

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Bryonia cretica D4	120 mg
Aconitum napellus D4	150 mg
Phosphorus D5	30 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
8417	13134	1013134	tablečių talpyklė	N50		Nereceptinis	LT/1/2000/2814/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2020-02-27	Išregistruotas
2012-02-28	Perregistruotas
2000-11-09	Registruotas